PARTNER WITH CLYRA
What development decision are you trying to make?
Clyra works with oncology drug developers, translational medicine teams, and scientific collaborators on asset-specific patient-stratification and biomarker questions.
Start with one asset, one indication, and one high-value question.
01 — Define the decision
Identify the clinical or translational question that matters to the program.
02 — Assemble the evidence
Determine which molecular, clinical, treatment, and outcome data can inform it.
03 — Identify subgroup hypotheses
Use the Clyra platform to characterize biologically distinct patient populations and outcome-linked tumor states.
04 — Build the validation path
Prioritize the analyses and datasets needed to test the hypothesis in human development.
Discuss your program.
Share the asset, indication, and development decision your team is working through. Clyra will follow up to learn whether a focused translational program is a fit.